Skip to main content
GutCited
Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).
Figure 1. Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).

More Figures from This Paper

Cite This Figure

![Figure 1: Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).](https://pdfs.citedhealth.com/figures/32412188/182.png)

> Source: Muhammad Ilyas et al. "The Resurgence of Measles Infection and its Associated Complications in Early Ch." *Polish journal of microbiology*, 2020. PMID: [32412188](https://pubmed.ncbi.nlm.nih.gov/32412188/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/32412188/182.png" alt="Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100)." />
  <figcaption>Figure 1. Fig. 1. The overall distribution of anti-measles antibody (IgM) in patients’ sera (n = 100).<br>  Source: Muhammad Ilyas et al. "The Resurgence of Measles Infection and its Associated Complications in Early Ch." <em>Polish journal of microbiology</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32412188/">32412188</a></figcaption>
</figure>